DEP Updates from AGM Presentation November 2020.
- DEP docetaxel - Was 37 now 40 (+3) - Not sure what trial figures are said to be for phase 2.
- DEP cabazitaxel - Was 17 with phase 2 first stage trail participant aim of 30 - Now 35 (+18) - appears over and above aim
- DEP Irinotecan - Phase 2 was 27 now 40 +13 - Not sure on population target
Appears to me that recruitment has gone well and at least one trial is fully recruited, anyone else have views on enrollment numbers please?
DEP Enrollment Update
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
